Search - tctmd.com

Displaying 381 - 400 of 4702

Sort: Relevancy | Date

Presentation NY Valves 2025

Presentation 3: Siegel TAVR

Presenter: Pradeep K. Yadav

June 26, 2025

Presentation NY Valves 2025

Presentation 2: DurAVR

Presenter: Ole De Backer

June 26, 2025

Presentation NY Valves 2025

Presentation 1: Encantor TAVR

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Presenter: Jadon Ray Rajagopal

June 26, 2025

Presentation NY Valves 2025

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Presenter: Bo Yang

June 26, 2025

Presentation NY Valves 2025

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

Presenter: Tej Sheth

June 26, 2025

Presentation NY Valves 2025

An Algorithm for Managing Catastrophic Hypotension During TAVR

Presenter: James M. McCabe

June 26, 2025

Presentation NY Valves 2025

Valve Embolization: Treatment Strategies

Presenter: Stanley J. Chetcuti

June 26, 2025

Presentation NY Valves 2025

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Presenter: Gregory P. Fontana

June 26, 2025

Presentation NY Valves 2025

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Presenter: George D. Dangas

June 26, 2025

Presentation NY Valves 2025

Long-Term Outcomes After TAVR With a Self-Expanding Prosthesis

Presenter: Won-Keun Kim

June 26, 2025

Presentation NY Valves 2025

Transcarotid Access for TAVR Using a Balloon Expandable Valve: Contemporary Results from a Real-World Registry

Presenter: Keith B. Allen

June 26, 2025

Presentation NY Valves 2025

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

Presenter: Alexandra J. Lansky

June 26, 2025

Presentation NY Valves 2025

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

Presenter: Tamim M. Nazif

June 26, 2025

Presentation NY Valves 2025

Echo Assessment Remains the Gold Standard

Presenter: Leo Marcoff

June 26, 2025

Presentation NY Valves 2025

Not if the Invasive Gradients Look Fine

Presenter: Brian K. Whisenant

June 26, 2025

Presentation NY Valves 2025

Paravalular Leak After TAVR: When to Treat and Options for Closure

Presenter: Mackram F. Eleid

June 26, 2025

Presentation NY Valves 2025

A Femoral Complication Where Alternative Access Should Have Been Considered

Presenter: Rajiv Tayal

June 26, 2025

Presentation NY Valves 2025

When the PCI Performed Prior to TAVR Goes South, Maybe I Should Have Waited Until After the TAVR . . .

Presenter: Mahesh V. Madhavan

June 26, 2025

Advertisement

Presentation 3: Siegel TAVR

Presentation 2: DurAVR

Presentation 1: Encantor TAVR

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

An Algorithm for Managing Catastrophic Hypotension During TAVR

Valve Embolization: Treatment Strategies

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Long-Term Outcomes After TAVR With a Self-Expanding Prosthesis

Transcarotid Access for TAVR Using a Balloon Expandable Valve: Contemporary Results from a Real-World Registry

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

Echo Assessment Remains the Gold Standard

Not if the Invasive Gradients Look Fine

Paravalular Leak After TAVR: When to Treat and Options for Closure

A Femoral Complication Where Alternative Access Should Have Been Considered

When the PCI Performed Prior to TAVR Goes South, Maybe I Should Have Waited Until After the TAVR . . .

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content